EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Therapeutic potential of salicylamide derivatives for combating viral infections

Jimin Xu, Yu Xue, Andrew A Bolinger, Jun Li, Mingxiang Zhou, Haiying Chen, Hongmin Li, Jia Zhou iD

Medicinal Research Reviews · 2023-07 · 43 (4) · 897-931

DOI: 10.1002/med.21940 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, online erschienen am 10.03.2023. Verfasst von Jimin Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, USA. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 225 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIAID NIH HHS, NIDA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since time immemorial human beings have constantly been fighting against viral infections. The ongoing and devastating coronavirus disease 2019 pandemic represents one of the most severe and most significant public health emergencies in human history, highlighting an urgent need to develop broad‐spectrum antiviral agents. Salicylamide (2‐hydroxybenzamide) derivatives, represented by niclosamide and nitazoxanide, inhibit the replication of a broad range of RNA and DNA viruses such as flavivirus, influenza A virus, and coronavirus. Moreover, nitazoxanide was effective in clinical trials against different viral infections including diarrhea caused by rotavirus and norovirus, uncomplicated influenza A and B, hepatitis B, and hepatitis C. In this review, we summarize the broad antiviral activities of salicylamide derivatives, the clinical progress, and the potential targets or mechanisms against different viral infections and highlight their therapeutic potential in combating the circulating and emerging viral infections in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansThiazolesNitro CompoundsAntiviral AgentsSalicylamidesVirus Replication

Stichwörter der Autor:innen

broad-spectrum antiviral agentsinfectious diseasesniclosamidenitazoxanidesalicylamide derivatives

Substanzen

nitazoxanideThiazolesNitro CompoundsAntiviral AgentssalicylamideSalicylamides

Autor:innen und Institutionen

  • Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX, USA.
  • Department of Pharmacology and Toxicology, R. Ken Coit College of Pharmacy, University of Arizona, Tucson, Arizona, USA.

ORCID-Profile: Jia Zhou

Förderung

  • NIH HHS
  • NIAID NIH HHS
  • NIDA NIH HHS

Zitieren

APA

Xu, J., Xue, Y., Bolinger, A. A., Li, J., Zhou, M., Chen, H., Li, H., & Zhou, J. (2023). Therapeutic potential of salicylamide derivatives for combating viral infections. Medicinal Research Reviews, 43(4), 897-931. https://doi.org/10.1002/med.21940

Vancouver

Xu J, Xue Y, Bolinger AA, Li J, Zhou M, Chen H, et al. Therapeutic potential of salicylamide derivatives for combating viral infections. Medicinal Research Reviews. 2023;43(4):897-931. doi:10.1002/med.21940

BibTeX
@article{Xu2023,
  author = {Xu, Jimin and Xue, Yu and Bolinger, Andrew A and Li, Jun and Zhou, Mingxiang and Chen, Haiying and Li, Hongmin and Zhou, Jia},
  title = {Therapeutic potential of salicylamide derivatives for combating viral infections},
  journal = {Medicinal Research Reviews},
  year = {2023},
  volume = {43},
  number = {4},
  pages = {897--931},
  doi = {10.1002/med.21940}
}
Kostenlos starten →